GSK plc (GSK) Financials

GSK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 109.4 billion 79.1 billion
Dec. 31, 2025 82.0 billion 60.5 billion
Sept. 30, 2025 111.0 billion 82.5 billion
June 30, 2025 111.5 billion 84.5 billion

GSK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 921.4 million ?
Dec. 31, 2025 2.0 billion ?
Sept. 30, 2025 3.5 billion ?
June 30, 2025 2.0 billion ?

GSK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.4 billion
Dec. 31, 2025 843.5 million
Sept. 30, 2025 3.6 billion
June 30, 2025 2.3 billion

GSK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.0 billion 24.4 billion -
Dec. 31, 2025 4.6 billion 19.7 billion 1.1 billion
Sept. 30, 2025 6.0 billion 27.0 billion -
June 30, 2025 6.8 billion 28.8 billion -

GSK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.7 billion
Dec. 31, 2025 1.4 billion
Sept. 30, 2025 2.8 billion
June 30, 2025 2.8 billion

GSK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 584.8 million 2.2 billion 2.8 billion -
Dec. 31, 2025 752.9 million 3.2 billion 3.5 billion -
Sept. 30, 2025 575.9 million 2.3 billion 3.0 billion -
June 30, 2025 869.1 million 2.8 billion 2.9 billion -

GSK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 10.1 billion 2.5 billion
Dec. 31, 2025 11.6 billion 3.6 billion
Sept. 30, 2025 11.5 billion 3.0 billion
June 30, 2025 11.0 billion 3.0 billion

GSK

Price: $51.52

52 week price:
35.45
61.70

Dividend Yield: 3.62%

5-year range yield:
2.69%
6.69%

Forward Dividend Yield: 3.43%

Payout Ratio: 52.47%

Payout Ratio Range:
-1055.17%
938.88%

Dividend Per Share: 1.76 USD

Earnings Per Share: 3.86 USD

P/E Ratio: 13.05

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Volume: 3.7 million

Ebitda: 2.0 billion

Market Capitalization: 100.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 43

DGR3: 0.42%

DGR5: 0.12%

DGR10: -2.10%

DGR20: 1.63%

Links: